Louisiana Legislature Approves Bill Classifying Abortion Pills as Controlled Dangerous Substances

BATON ROUGE, La. — Louisiana lawmakers have passed a groundbreaking bill that reclassifies two abortion-inducing drugs, mifepristone and misoprostol, as controlled and dangerous substances. The bill received final legislative approval on Thursday and is anticipated to be signed into law by the governor.

Supporters argue the reclassification will protect expectant mothers from coerced abortions, though only one such incident has been cited, occurring in Texas. Numerous doctors, however, warn that the new classification will complicate prescribing these medications, which are also used for other critical reproductive health needs.

The bill’s passage comes amid heightened national debate on abortion rights. The U.S. Supreme Court is currently deliberating on a case that could restrict access to mifepristone, though the justices seemed hesitant to limit the drug during oral arguments.

Louisiana’s GOP-dominated Legislature’s move could inspire similar actions in other Republican-led states seeking stricter abortion regulations. Louisiana already enforces a near-total abortion ban, covering both surgical and medical abortions. The new bill adds mifepristone and misoprostol to the list of Schedule IV drugs under the state’s Uniform Controlled Dangerous Substances Law, further restricting access.

This reclassification will necessitate specific licenses for doctors to prescribe the drugs, and mandate that the medications be stored in certified facilities, potentially far from rural clinics. Unauthorized possession without a valid prescription will be punishable by fines and jail time, though the bill includes protections for pregnant women who obtain the drugs without prescriptions for personal use.

Over 200 Louisiana doctors have expressed concern, signing a letter to lawmakers stating the measure could hinder physicians’ ability to prescribe necessary treatments and cause confusion and fear among patients. They warn that delays in accessing these drugs could worsen outcomes in a state already struggling with one of the highest maternal mortality rates in the nation.

“This goes too far. We have not properly vetted this with the health care community and I believe it’s going to lead to further harm down the road,” said Democratic Sen. Royce Duplessis, who opposed the measure. “There’s a reason we rank at the bottom in terms of maternal health outcomes, and this is why.”

The bill, including the reclassification amendment, originated in the Senate to address “coerced criminal abortion by means of fraud.” Sen. Thomas Pressly, the bill’s sponsor, added the reclassification following an incident involving his sister, Catherine Herring of Texas, whose husband secretly gave her seven misoprostol pills to induce an abortion without her consent.

The measure now awaits the governor’s signature to become law, marking a significant step in Louisiana’s ongoing efforts to tighten abortion restrictions.

PRAYING FOR FAMILIES AND COMMUNITIES

Heavenly Father, we lift up the families and communities in Louisiana impacted by the new legislation on abortion-inducing drugs. Grant wisdom and compassion to lawmakers and medical professionals as they navigate these changes. Comfort those who may face increased challenges in accessing necessary healthcare. Bring peace to those who are fearful or confused, and protect all expectant mothers from harm. Guide our society towards greater understanding and empathy, fostering a culture that values both life and the health of women. May Your love and justice prevail in every decision and action. In Jesus’ name, we pray. Amen.